Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve the unaudited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech Ltd has informed BSE that its Board of Directors will meet on Thursday, 7th August 2025 at the registered office. The main agenda item is to consider and approve the unaudited standalone financial results for the quarter ended 30th June 2025 (Q1 FY26). Any other matter may be discussed with the chairman's permission. The trading window for dealing in the company's securities has been closed from 1st July 2025 and will reopen 48 hours after the results are made public.
This is a routine procedural filing. Investors should watch for the Q1 FY26 results announcement on or shortly after 7th August 2025 to gauge the company's quarterly performance. No material business or financial impact arises from the intimation itself.